(Q39464865)

12 September 2017

1 reference

title

Anatomy and pathology of the basal ganglia (English)

1 reference

12 September 2017

McGeer PL

1

1 reference

12 September 2017

McGeer EG

series ordinal

2

1 reference

12 September 2017

Itagaki S

series ordinal

3

1 reference

12 September 2017

Mizukawa K

series ordinal

4

1 reference

12 September 2017

language of work or name

1 reference

1 August 1987

1 reference

Canadian Journal of Neurological Sciences

12 September 2017

published in

1 reference

12 September 2017

volume

14

1 reference

12 September 2017

issue

3 Suppl

1 reference

12 September 2017

page(s)

363-372

1 reference

Purification and chemical characterization of the receptor for interleukin 2 from activated human T lymphocytes and from a human T-cell lymphoma cell line

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Anti-neuronal antibody in Sydenham's chorea

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Neurotransmitters in the basal ganglia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Transplantation of cultured fetal human adrenal chromaffin cells to rat brain

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Loss of high affinity neurotensin receptors in substantia nigra from parkinsonian subjects

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Glycine Receptors in the Human Substantia Nigra as Defined by [3H]Strychnine Binding

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Regional Distribution of Neurotransmitter Synthesizing Enzymes in the Basal Ganglia of Human Brain

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Transplantation of cultured human spinal cord cells into the rat motor cortex: use of Phaseolus vulgaris leucoagglutinin as a cell marker

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Opioid peptides in Huntington's disease: alterations in prodynorphin and proenkephalin system

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Lesions of the putamen and dystonia: CT and magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

The molecules of the immune system

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Dopamine D2 receptor density remains constant in treated Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Functional recovery in a rat model of Parkinson's disease following transplantation of cultured human sympathetic neurons

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

THE RAPID PRODUCTION OF ACUTE DISSEMINATED ENCEPHALOMYELITIS IN RHESUS MONKEYS BY INJECTION OF HETEROLOGOUS AND HOMOLOGOUS BRAIN TISSUE WITH ADJUVANTS.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Characterization of brain proteins reacting in vitro with anti-neuronal antibodies in patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Loss of substance P and Enkephalin immunoreactivity in the human substantia nigra after striato-pallidal infarction

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Studies on neurotransmitter markers and striatal neuronal cell density in Huntington's disease and dentatorubropallidoluysian atrophy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Quantitative autoradiography of neurotransmitter receptors in Huntington disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Brain histidine decarboxylase activity in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Neurotransmitter receptor alterations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

L-dopa reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatum

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Adrenergic receptors on cerebral microvessels in control and parkinsonian subjects

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Methionine-enkephalin and substance P in the basal ganglia of normals, Parkinson patients, Huntington patients, and schizophrenics. A qualitative immunohistochemical study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Distribution of choline acetyltransferase-containing neurons of the hypothalamus

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Advanced catecholaminergic disturbances in the brain in a case of Wilson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037756

7 January 2021

10.1017/S0317167100037756

Identifiers

DOI

0 references

1 reference